Urology · Florence, AL
NPI
1528389517
Since 2010
Specialty
Urology
Code 208800000X
Group practices
3
Medicare group memberships
Hospitals
3
Hospital affiliations
541 W. College Street, Suite 3300
Florence, AL, 35630
Phone (256) 766-6026
Groups this clinician bills Medicare through
Medicare paid, 2024
$124K
3,343 services
Medicare patients, 2024
599
Average age 75
Drug cost, 2024
$611K
2,420 prescriptions
Company payments, 2025
$1,027
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Dustin C Hyatt was code 81001 (clinical chemistry), 711 times for 478 patients. In total Dustin C Hyatt billed 3,343 services in 60 codes, and Medicare paid $124K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-08-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 81001 Clinical Chemistry | Office | 711 | 478 | $3.09 | $2,196 |
| 99213 Office E&M - Established | Office | 554 | 402 | $56.73 | $31K |
| 36415 Venipuncture Blood Collection | Office | 263 | 196 | $6.35 | $1,670 |
| 99214 Office E&M - Established | Office | 123 | 105 | $78.92 | $9,707 |
| J9217 Leuprolide acetate (for depot suspension), 7.5 mg | Office | 111 | 15 | $140.66 | $16K |
| 99231 Hospital E&M - Subsequent | Facility | 87 | 48 | $38.07 | $3,312 |
| 99221 Hospital E&M - Initial | Facility | 54 | 51 | $56.60 | $3,057 |
| 99204 Office E&M - New | Office | 52 | 52 | $108.40 | $5,637 |
| 52000 Cystourethroscopy | Office | 39 | 35 | $156.80 | $6,115 |
| 96402 Chemotherapy Administration | Office | 37 | 15 | $23.74 | $879 |
| 51798 Ultrasound - Nonspecific | Office | 35 | 31 | $7.54 | $264 |
| 99203 Office E&M - New | Office | 32 | 32 | $65.09 | $2,083 |
| 52332 Cystourethroscopy | Facility | 12 | 12 | $110.24 | $1,323 |
| 99222 Hospital E&M - Initial | Facility | 12 | 12 | $93.68 | $1,124 |
| 52356 Calculus Removal - Urinary | Facility | 11 | 11 | $308.65 | $3,395 |
By year: 2022 $123K for 3,211 services; 2023 $121K for 3,453 services; 2024 $124K for 3,343 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81001 Clinical Chemistry | 711 | 478 | $3.09 | $2,196 |
| 36415 Venipuncture Blood Collection | 263 | 196 | $6.35 | $1,670 |
Medicare prescription drug claims, 2024
In 2024, the drug Dustin C Hyatt prescribed most often to Medicare patients was Tamsulosin Hcl, with 844 prescriptions and refills. In total Dustin C Hyatt wrote 2,420 Medicare prescriptions that cost $611K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tamsulosin Hcl Generic | 844 | 2,222 | 262 | $14K |
| Finasteride Generic | 420 | 1,163 | 124 | $6,880 |
| Testosterone Cypionate Generic | 215 | 287 | 36 | $6,941 |
| Oxybutynin Chloride Generic | 132 | 335 | 54 | $2,961 |
| Gemtesa Vibegron | 67 | 105 | 20 | $49K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 61 | 61 | 52 | $284 |
| Oxybutynin Chloride Er Oxybutynin Chloride | 60 | 140 | 19 | $1,991 |
| Myrbetriq Mirabegron | 58 | 76 | 13 | $26K |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 57 | 126 | 18 | $2,783 |
| Ciprofloxacin Hcl Generic | 48 | 48 | 43 | $144 |
| Terazosin Hcl Generic | 47 | 125 | 14 | $1,051 |
| Tolterodine Tartrate Generic | 44 | 126 | 16 | $6,856 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 43 | 55 | 29 | $132 |
| Testosterone Generic | 29 | 35 | Under 11 | $4,539 |
| Tolterodine Tartrate Er Tolterodine Tartrate | 26 | 70 | Under 11 | $3,450 |
Brand drugs: - claims; generic drugs: 2,239 claims; opioid claims: 66.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Dustin C Hyatt $1,027 ($1,027 in general payments such as food, travel and fees) from 3 companies. The largest payer was Boston Scientific Corporation with $957.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.